Seres Therapeutics, Inc. MCRB
$4.87
+1.04%
at last close
Financials (TTM)
- Revenue
- $1.88 million
- Net Income
- $-22,463,000
- Net Margin
- -1192.94%
- Return on Equity
- -65.05%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.40
- Price / Sales
- 25.71
Over the trailing twelve months, Seres Therapeutics, Inc. generated revenue of $1.88 million and net income of $-22,463,000, a net margin of -1192.94%.
At the last closing price of $4.87, MCRB trades at 25.71 times sales, with a market capitalization of $48.41 million.
Key Stats
- Last Close
- $4.87
- Market Cap
- $48.41 million
- 52-Week Range
- $4.59 – $29.98
- Average Volume
- 103K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.